Keating Investment Counselors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,418
| Closed | -$503K | – | 72 |
|
|
2024
Q1 | $503K | Sell |
7,418
-275
| -4% | -$18.6K | 0.16% | 56 |
|
|
2023
Q4 | $518K | Sell |
7,693
-75
| -1% | -$5.05K | 0.19% | 63 |
|
|
2023
Q3 | $526K | Buy |
+7,768
| New | +$526K | 0.18% | 60 |
|
|
2021
Q2 | – | Sell |
-4,489
| Closed | -$223K | – | 61 |
|
|
2021
Q1 | $223K | Sell |
4,489
-700
| -13% | -$34.8K | 0.11% | 58 |
|
|
2020
Q4 | $259K | Hold |
5,189
| – | – | 0.13% | 55 |
|
|
2020
Q3 | $284K | Hold |
5,189
| – | – | 0.15% | 51 |
|
|
2020
Q2 | $274K | Buy |
5,189
+304
| +6% | +$16.1K | 0.15% | 50 |
|
|
2020
Q1 | $218K | Sell |
4,885
-3,150
| -39% | -$141K | 0.13% | 59 |
|
|
2019
Q4 | $401K | Sell |
8,035
-100
| -1% | -$4.99K | 0.18% | 56 |
|
|
2019
Q3 | $363K | Sell |
8,135
-1,700
| -17% | -$75.9K | 0.16% | 57 |
|
|
2019
Q2 | $406K | Sell |
9,835
-13,890
| -59% | -$573K | 0.18% | 53 |
|
|
2019
Q1 | $959K | Sell |
23,725
-56,385
| -70% | -$2.28M | 0.43% | 45 |
|
|
2018
Q4 | $3.04M | Sell |
80,110
-28,125
| -26% | -$1.07M | 1.54% | 27 |
|
|
2018
Q3 | $4.28M | Sell |
108,235
-119,850
| -53% | -$4.74M | 1.84% | 24 |
|
|
2018
Q2 | $8.01M | Sell |
228,085
-20,575
| -8% | -$722K | 3.8% | 8 |
|
|
2018
Q1 | $8.7M | Sell |
248,660
-9,500
| -4% | -$332K | 4.01% | 6 |
|
|
2017
Q4 | $8.96M | Sell |
258,160
-200
| -0.1% | -$6.94K | 3.81% | 6 |
|
|
2017
Q3 | $8.75M | Sell |
258,360
-3,200
| -1% | -$108K | 3.8% | 5 |
|
|
2017
Q2 | $8.92M | Sell |
261,560
-2,025
| -0.8% | -$69K | 3.9% | 6 |
|
|
2017
Q1 | $8.21M | Buy |
263,585
+2,200
| +0.8% | +$68.5K | 3.66% | 6 |
|
|
2016
Q4 | $7.14M | Buy |
261,385
+11,735
| +5% | +$321K | 3.37% | 9 |
|
|
2016
Q3 | $8.2M | Buy |
249,650
+237,725
| +1,994% | +$7.81M | 3.99% | 6 |
|
|
2016
Q2 | $360K | Buy |
+11,925
| New | +$360K | 0.18% | 58 |
|